IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bob L who wrote (1582)	7/13/1998 12:50:00 AM
From: Maurice Winn	1 Recommendation Read Replies (1) of 1762

Bob, "More serious competition might come from IDPH. They have shown good results in aggressive lymphomas with a combination of Rituxan and chemotherapy. The side effects are worse than oncolym, but the response rate is higher. However, the trials have been with only a small number of patients so far. The results may not be as favorable with larger numbers of patients." This makes me feel ill! Maurice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next